SBCEF-TZ 1.125GM Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBCEF-TZ 1.125GM
Ceftriaxone Sodium 1000mg + Tazobactam 125mg
SBCEF-TZ 1.125GM (Ceftriaxone Sodium 1000mg + Tazobactam 125mg) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SBCEF-TZ 1.125GM deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store between 2°C to 8°C or below 25°C as indicated on label. Protect from light.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBCEF-TZ 1.125GM features Ceftriaxone Sodium 1000mg + Tazobactam 125mg prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Apply for Exclusive Marketing Rights of SBCEF-TZ 1.125GM
Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.
Questions Regarding SBCEF-TZ 1.125GM
What is the therapeutic indication and composition of SBCEF-TZ 1.125GM?
SBCEF-TZ 1.125GM contains Ceftriaxone Sodium 1000mg + Tazobactam 125mg indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SBCEF-TZ 1.125GM?
SBCEF-TZ 1.125GM is supplied in tamper-evident Single Dose Sterile Vial with Ampoule & WFI, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBCEF-TZ 1.125GM?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBCEF-TZ 1.125GM along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBCEF-TZ 1.125GM is categorized as Schedule H1 Prescription Drug with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Injection
View all Injection →
SBCEF-S 375MG
Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection
